NASDAQ:CHEK Check-Cap (CHEK) Stock Price, News & Analysis → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free CHEK Stock Alerts $2.29 +0.02 (+0.88%) (As of 03:05 PM ET) Add Compare Share Share Today's Range$2.22▼$2.3050-Day Range$1.87▼$3.1152-Week Range$1.27▼$4.63Volume15,270 shsAverage Volume206,321 shsMarket Capitalization$13.40 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Get Check-Cap alerts: Email Address Check-Cap MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy2.95% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.79Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($2.05) to ($0.68) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.21 out of 5 starsMedical Sector752nd out of 908 stocksX - Ray Apparatus & Tubes Industry1st out of 1 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Check-Cap. Previous Next 5.0 Short Interest Percentage of Shares Shorted2.95% of the float of Check-Cap has been sold short.Short Interest Ratio / Days to CoverCheck-Cap has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Check-Cap has recently decreased by 78.15%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldCheck-Cap does not currently pay a dividend.Dividend GrowthCheck-Cap does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CHEK. Previous Next 3.2 News and Social Media Coverage News SentimentCheck-Cap has a news sentiment score of 0.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.33 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Check-Cap this week, compared to 1 article on an average week.Search Interest2 people have searched for CHEK on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Check-Cap insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.48% of the stock of Check-Cap is held by insiders.Percentage Held by InstitutionsOnly 1.07% of the stock of Check-Cap is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Check-Cap are expected to grow in the coming year, from ($2.05) to ($0.68) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Check-Cap is -0.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Check-Cap is -0.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCheck-Cap has a P/B Ratio of 0.26. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsThe Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late. About Check-Cap Stock (NASDAQ:CHEK)Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.Read More CHEK Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CHEK Stock News HeadlinesApril 23, 2024 | americanbankingnews.comStockNews.com Initiates Coverage on Check-Cap (NASDAQ:CHEK)March 26, 2024 | msn.comAI-Powered Real Estate Marketplace Nobul AI To Acquire Medical-Diagnostics Company Check-CapApril 26, 2024 | Weiss Ratings (Ad)The Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.March 26, 2024 | investorplace.comWhy Is Check-Cap (CHEK) Stock Up 44% Today?March 25, 2024 | prnewswire.comNobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination AgreementMarch 19, 2024 | msn.comWhat the Chargers can do with their cap space after roster movesMarch 8, 2024 | msn.comHow much cap space do the Seahawks have after trio of Tuesday cuts?February 24, 2024 | jaguarswire.usatoday.comLarger than expected salary cap means more space for JaguarsApril 26, 2024 | Weiss Ratings (Ad)The Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.February 23, 2024 | msn.comBengals emerge big winners with updated cap space after 2024 cap revealFebruary 10, 2024 | investing.comCheck Cap Ltd (CHEK)December 22, 2023 | finance.yahoo.comSYMETRYX COMMENTS ON SUCCESSFUL CAMPAIGN AT CHECK-CAP LTDDecember 14, 2023 | finance.yahoo.comCheck-Cap Board of Directors Issues Letter to ShareholdersDecember 8, 2023 | finance.yahoo.comCITING THE MANY FDA ADVERSE EFFECTS TO KEYSTONE DENTAL - CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER ALSO RECOMMENDS VOTING FOR THE SYMETRYX BOARD NOMINEESDecember 7, 2023 | finance.yahoo.comLeading Independent Proxy Advisory Firm ISS Recommends Check-Cap Shareholders Vote FOR the Keystone Dental Business Combination AgreementDecember 5, 2023 | finance.yahoo.comCHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER AND FOR THE SYMETRYX BOARD OF DIRECTORS NOMINEESNovember 29, 2023 | benzinga.comCheck-Cap Stock (NASDAQ:CHEK) Earnings Dates and Earning CallsNovember 28, 2023 | benzinga.comCheck-Cap Stock (NASDAQ:CHEK) Dividends: History, Yield and DatesNovember 27, 2023 | benzinga.comCheck-Cap: Q3 Earnings InsightsNovember 27, 2023 | msn.comCheck-Cap GAAP EPS of -$0.44November 27, 2023 | markets.businessinsider.comCheck-Cap Posts Narrower Loss In Q3 - Quick FactsNovember 27, 2023 | finance.yahoo.comCheck-Cap Reports Third Quarter 2023 Financial Results and Provides a Corporate UpdateNovember 7, 2023 | morningstar.comCheck-Cap Ltd CHEKOctober 31, 2023 | markets.businessinsider.comNotice of Extraordinary General Meeting of ShareholdersOctober 27, 2023 | msn.comCheck out some of the caps you can get at a Bucks game this yearOctober 26, 2023 | bloomberg.comKazakhstan Aims to Cut Loan-Rate CapOctober 19, 2023 | finance.yahoo.comCheck-Cap Issues Letter to Shareholders Regarding Proposed Merger with Keystone Dental HoldingsSee More Headlines Receive CHEK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Check-Cap and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/27/2023Today4/26/2024Next Earnings (Estimated)5/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry X - ray apparatus & tubes Sub-IndustryN/A Current SymbolNASDAQ:CHEK CUSIPN/A CIK1610590 Webwww.check-cap.com Phone972546706451Fax972-4821-1267Employees85Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-19,110,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-47.85% Return on Assets-43.50% Debt Debt-to-Equity RatioN/A Current Ratio17.60 Quick Ratio17.60 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$8.57 per share Price / Book0.27Miscellaneous Outstanding Shares5,850,000Free Float5,822,000Market Cap$13.46 million OptionableNot Optionable Beta0.28 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Alex Ovadia (Age 62)CEO & Director Comp: $409.35kDr. Yoav Kimchy Ph.D. (Age 63)Founder & Interim CTO Comp: $362.65kMr. Joshua Belkar (Age 55)Vice President of Operations Comp: $269.57kMs. Iris Even-TovInterim Chief Financial OfficerMs. Noa Reshef M.B.A.Director of Human ResourcesKey CompetitorsAvalo TherapeuticsNASDAQ:AVTXNanoViricidesNYSE:NNVCTonix PharmaceuticalsNASDAQ:TNXPBiotricityNASDAQ:BTCYSenti BiosciencesNASDAQ:SNTIView All Competitors CHEK Stock Analysis - Frequently Asked Questions Should I buy or sell Check-Cap stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Check-Cap in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" CHEK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CHEK, but not buy additional shares or sell existing shares. View CHEK analyst ratings or view top-rated stocks. How have CHEK shares performed in 2024? Check-Cap's stock was trading at $2.08 on January 1st, 2024. Since then, CHEK stock has increased by 8.7% and is now trading at $2.26. View the best growth stocks for 2024 here. Are investors shorting Check-Cap? Check-Cap saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 131,100 shares, a decline of 78.2% from the March 31st total of 600,000 shares. Based on an average trading volume of 251,300 shares, the days-to-cover ratio is presently 0.5 days. Approximately 3.0% of the company's shares are short sold. View Check-Cap's Short Interest. When is Check-Cap's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our CHEK earnings forecast. How were Check-Cap's earnings last quarter? Check-Cap Ltd. (NASDAQ:CHEK) announced its earnings results on Monday, November, 27th. The medical research company reported ($0.44) earnings per share for the quarter, beating analysts' consensus estimates of ($0.83) by $0.39. When did Check-Cap's stock split? Check-Cap shares reverse split on Friday, November 25th 2022. The 1-20 reverse split was announced on Friday, November 25th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, November 25th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What other stocks do shareholders of Check-Cap own? Based on aggregate information from My MarketBeat watchlists, some companies that other Check-Cap investors own include Alibaba Group (BABA), Navios Maritime Partners (NMM), New Residential Investment (NRZ), Heat Biologics (HTBX), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Acasti Pharma (ACST), Avinger (AVGR), Biocept (BIOC) and Purple Biotech (KTOV). When did Check-Cap IPO? Check-Cap (CHEK) raised $13 million in an IPO on Thursday, February 19th 2015. The company issued 1,200,000 shares at a price of $10.00-$12.00 per share. Chardan Capital Markets and Maxim Group served as the underwriters for the IPO and Feltl and Company was co-manager. How do I buy shares of Check-Cap? Shares of CHEK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CHEK) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Check-Cap Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.